This allows us to compare the broader range of biology to find true candidates for GLP-1 approaches
Subjects with complicated or severe diseases (e.g., stroke, diabetic complications, cardiac diseases, renal/hepatic disorders, psychiatric disorders, cancers) were excluded
Interestingly, most ligand interactions with TRF1 TRFH (12/19 ligands) involved the side chains of R131 or Q127, whereas only three fragments formed direct interactions with the more flexible R102 and E106 residues
Patients with a history of pancreatitis require careful individual assessment and monitoring given the association between GLP-1 medications and pancreatitis risk
A 20-unit draw with a 3-unit air bubble only delivers approximately 17 units of actual semaglutide solution
Counterfeit and substandard GLP-1 products are a documented safety risk